United States

Allergan in the United States

United States - Allergan

On March 17, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company has broad commercial reach extending across approximately 100 countries and is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team.

The Actavis + Allergan Brand portfolio features six blockbuster franchises in key therapeutic categories, including Dermatology and Aesthetics; CNS; Eye Care; Women’s Health and Urology; GI and Cystic Fibrosis; and Cardiovascular and Infectious Disease. Supporting these blockbuster franchises is the company’s industry-leading specialty and primary care U.S. sales force with extraordinary marketing reach and increased relevance with primary care physicians and specialists.

Driving continued innovation and growth is the combined company’s strong commitment to R&D, with an investment of ~$1.7 billion in 2015 alone, focused on strategic development of innovative and durable value-enhancing products within brands, generics, biologics and OTC portfolios.

Allergan US Administrative Headquarters

Allergan, Parsippany

  • Morris Corporate Center III
  • 400 Interpace Parkway
  • Parsippany, NJ 07054
  • Tel: +1 862 261 7000

Get direction from


Jersey City Office

Allergan, Jersey City

  • Harborside Financial Center
  • Plaza V, Suite 1900
  • Jersey City
  • NJ 07311-4994
  • +1 866 369 5227 — Toll-free
  • Tel: +1 201 427 8000

Get direction from


Irvine Office

Allergan, Irvine

  • 2525 Dupont Dr.
  • Irvine, CA 92612
  • Tel: +1 714 246 4500

Get direction from


Allergan US Government Affairs Office

Allergan, Washington D.C.

  • 500 North Capitol St. NW, Suite 330
  • Washington, DC 20001

Get direction from